Volume 21, Issue 24 2412566
Research Article

Supramolecular Nanoplatforms with Activable Ultrasound and Magnetic Resonance Imaging for Cancer Diagnosis and Therapy

Taoxia Liu

Taoxia Liu

State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing, 100029 P. R. China

Search for more papers by this author
Fanqi Liu

Fanqi Liu

State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing, 100029 P. R. China

Search for more papers by this author
Xindi Li

Xindi Li

State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing, 100029 P. R. China

Search for more papers by this author
Suying Xu

Corresponding Author

Suying Xu

State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing, 100029 P. R. China

E-mail: [email protected]; [email protected]

Search for more papers by this author
Leyu Wang

Corresponding Author

Leyu Wang

State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing, 100029 P. R. China

E-mail: [email protected]; [email protected]

Search for more papers by this author
First published: 24 April 2025

Abstract

Excellent multifunctional platforms for cancer diagnosis and treatment are highly desirable. Herein, multifunctional nanocomposites are constructed by utilizing Mn2+ to coordinate to the imidazole moiety anchored on CuO2 nanoparticles through cyclodextrin-adamantane interaction. The encapsulated CuO2 nanoparticles (NPs) can generate hydrogen peroxide (H2O2) at tumor sites under acidic conditions upon decomposition, which is further turned into oxygen (O2) under Mn2+ catalysis, facilitating both ultrasound and magnetic resonance imaging (MRI). Moreover, the proposed nanomedicine enhances reactive oxygen species (ROS) generation and depletes glutathione (GSH), leading to increased lipid peroxidation (LPO) and effective ferroptosis-mediated cancer therapy. Such a strategy presents a promising approach for the development of theranostics for imaging-guided tumor therapy.

Conflict of Interest

The authors declare no conflict of interest.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.